Report cover image

RenovoRx Inc (RNXT) - Product Pipeline Analysis, 2023 Update

Publisher GlobalData
Published Mar 29, 2024
Length 27 Pages
SKU # GBDT18694797

Description

Summary


RenovoRx Inc (RenovoRx) is a medical device company. The company develops solutions for targeted delivery of diagnostic, therapeutic agents and chemotherapeutic drugs targeting peripheral vascular system. Its proprietary Trans-Arterial Micro-Perfusion (TAMP), technology platform provides chemotherapy for the treatment of solid tumors in the peripheral system. RenovoRx lead product RenovoCath, a medical device system with dual-balloon infusion catheter that delivers intra-arterial chemotherapy directly to the tumor. It also investigating TIGeR-PaC, a systemic chemotherapy for pancreatic cancer. RenovoRx is headquartered in Los Altos, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company RenovoRx Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

27 Pages
RenovoRx Inc Company Overview
RenovoRx Inc Company Snapshot
RenovoRx Inc Pipeline Products and Ongoing Clinical Trials Overview
RenovoRx Inc – Pipeline Analysis Overview
RenovoRx Inc - Key Facts
RenovoRx Inc - Major Products and Services
RenovoRx Inc Pipeline Products by Development Stage
RenovoRx Inc Ongoing Clinical Trials by Trial Status
RenovoRx Inc Pipeline Products Overview
RenovoCath System - Bile Duct Cancer
RenovoCath System - Bile Duct Cancer Product Overview
RenovoCath System - Pancreatic Cancer
RenovoCath System - Pancreatic Cancer Product Overview
RenovoCath System - Pancreatic Cancer Clinical Trial
Retractable Coil - Interventional Oncology
Retractable Coil - Interventional Oncology Product Overview
RenovoRx Inc - Key Competitors
RenovoRx Inc - Key Employees
RenovoRx Inc - Locations And Subsidiaries
Head Office
Recent Developments
RenovoRx Inc, Recent Developments
Mar 12, 2024: RenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024
Dec 19, 2023: RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
Dec 13, 2023: RenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy Platform
Nov 16, 2023: RenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D.
Jul 31, 2023: RenovoRx to Present at the 43rd Annual Canaccord Genuity Growth Conference
Apr 17, 2023: RenovoRx presenting phase III clinical trial interim analysis data of the TIGeR-PaC study at American Association for Cancer Research Annual Meeting Underway in Orlando, Florida
Jan 18, 2023: RenovoRx announces initial results in pharmacokinetic (PK) substudy: Data on RenovoGem supports potential for RenovoTAMP therapy platform to increase local Gemcitabine (chemotherapy) delivery and decrease side effects of pancreatic cancer treatment
Jan 05, 2023: RenovoRx strengthens Intellectual Property (IP) portfolio with eighth US Patent
Dec 15, 2022: RenovoRx announces acceptance of four clinical data abstracts at the 2023 ASCO Gastrointestinal Cancers (ASCO GI) Symposium
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: RenovoRx Inc Pipeline Products and Ongoing Clinical Trials Overview
Table 2: RenovoRx Inc Pipeline Products by Equipment Type
Table 3: RenovoRx Inc Pipeline Products by Indication
Table 4: RenovoRx Inc, Key Facts
Table 5: RenovoRx Inc, Major Products and Services
Table 6: RenovoRx Inc Number of Pipeline Products by Development Stage
Table 7: RenovoRx Inc Pipeline Products Summary by Development Stage
Table 8: RenovoRx Inc Ongoing Clinical Trials by Trial Status
Table 9: RenovoRx Inc Ongoing Clinical Trials Summary
Table 10: RenovoCath System - Bile Duct Cancer - Product Status
Table 11: RenovoCath System - Bile Duct Cancer - Product Description
Table 12: RenovoCath System - Pancreatic Cancer - Product Status
Table 13: RenovoCath System - Pancreatic Cancer - Product Description
Table 14: RenovoCath System - Pancreatic Cancer - Targeted Intra-arterial Gemcitabine Versus Continuation of IV Gemcitabine Plus Nab-paclitaxel Following Induction with Sequential IV Gemcitabine Plus Nab-paclitaxel and Radiotherapy for Locally Advanced Pancreatic Cancer
Table 15: Retractable Coil - Interventional Oncology - Product Status
Table 16: Retractable Coil - Interventional Oncology - Product Description
Table 17: RenovoRx Inc, Key Employees
Table 18: Glossary
List of Figures
Figure 1: RenovoRx Inc Pipeline Products by Equipment Type
Figure 2: RenovoRx Inc Pipeline Products by Development Stage
Figure 3: RenovoRx Inc Ongoing Clinical Trials by Trial Status

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us